Parkside Oncology Clinic
49, Parkside
Wimbledon
SW19 5NB

Tel: 020 8247 3384
Fax: 020 8247 3385
PA. Ms Hilary Dummer
Email: hdummer@parkside-hospital.co.uk

Professor Trevor Powles - Emeritus Professor at the Institute of Cancer Research

Professor Trevor Powles is currently the Lead Clinician at The Parkside Oncology Clinic in Wimbledon, London. Previously Medical Director of Common Tumours at the Royal Marsden Hospital, Professor Powles was also Head of the Marsden's  Breast Cancer service.  As a recipient of the All Parties Parliamentary Award for outstanding achievement in Breast Cancer (2003), Trevor Powles has in December 2005 been awarded the Brinker Award for outstanding achievement in breast cancer.

Initially trained in endocrinology and then medical oncology, Professor Powles was appointed onto the consultant staff of the Royal Marsden Hospital in 1974 and since then has specialised exclusively in the treatment of breast cancer. During this time he  led a team dedicated to providing the very best clinical service for the treatment of breast cancer. He has also been responsible for leading innovative clinical research programs directed to the prevention, early diagnosis and new treatments for breast cancer. During this time the five year relapse free survival for patients with operable breast cancer at the Royal Marsden improved from about 50% to over 80%.

Professor Powles is now based at the Parkside Oncology Clinic, and is part of a multidisciplinary team offering a service for diagnosis and treatment of women with breast cancer and for the evaluation and monitoring of healthy women at increased risk of breast cancer.

The breast oncology service at Parkside Hospital and Parkside Oncology Clinic is able to offer all of the very latest proven treatments for breast cancer in a modern facility with the most therapeutic radiographers equipment and backed up by specialist oncology nurses and pharmacists, and therapeutic radiologists and physicists.

The main clinical interests for Professor Powles are now the assessment of women at increased risk usually because of a family history of breast cancer, the diagnosis of women with symptomatic or screen detected breast problems and the treatment of women with breast cancer.